Low Incidence of Paravalvular Leakage With the Balloon-Expandable Sapien 3 Transcatheter Heart Valve Daniel Wendt, MD, Fadi Al-Rashid, MD, Philipp Kahlert,

Slides:

Advertisements

Similar presentations

Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program Olaf Reinhartz, MD, Katsuhide Maeda, MD, Bruce A. Reitz, MD,

Advertisements

Transcatheter Aortic Valve-in-Valve Implantation Using Lotus Valve for Failed Surgical Bioprostheses Fausto Castriota, MD, Roberto Nerla, MD, Antonio.

Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H

Ali N. Azadani, PhD, Nicolas Jaussaud, MD, Peter B

High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients Danielle K. Farrington, MD, Patrick D. Kilgo,

Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.

Mitraclip Followed by Surgical Aortic Valve Replacement: Hybrid Techniques for Regurgitant Aortic and Mitral Valve Disease Kyle Eudailey, MD, Nadira.

Transcatheter and Surgical Aortic Valve Replacement in Dialysis Patients: A Propensity- Matched Comparison Dale M. Kobrin, BA, Fenton H. McCarthy, MD,

Benny Weksler, MD, Jennifer L. Sullivan, MD

Transcatheter Aortic Valve-in-Valve Implantation Using Lotus Valve for Failed Surgical Bioprostheses Fausto Castriota, MD, Roberto Nerla, MD, Antonio.

Magnitude of Negative Impact of Preoperative Heart Failure on Mortality During Aortic Valve Replacement in the Medicare Population Christina M. Vassileva,

Reply The Annals of Thoracic Surgery

Unusual Gastrointestinal Bleeding After Sutureless Aortic Valve Replacement: A Word of Caution Jules Iquille, MD, Joseph Nader, MD, Eric Colpart, MD,

Jiro Esaki, MD, PhD, Bradley G. Leshnower, MD, Jose N

Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting John V. Conte, MD, Thomas G. Gleason, MD, Jon.

Society of Thoracic Surgeons Score Is Superior to the EuroSCORE Determining Mortality in High Risk Patients Undergoing Isolated Aortic Valve Replacement

Philipp Kahlert, MD, FESC, Holger Eggebrecht, MD, FESC, Rolf A

The new St Jude Trifecta versus Carpentier-Edwards Perimount Magna and Magna Ease aortic bioprosthesis: Is there a hemodynamic superiority? Daniel Wendt,

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Impact of Liver Indicators on Clinical Outcome in Patients Undergoing Transcatheter Aortic Valve Implantation Daniel Wendt, MD, Philipp Kahlert, MD,

Severity of Preoperative Aortic Regurgitation Does Not Impact Valve Durability of Aortic Valve Repair Following the David V Valve Sparing Aortic Root.

Pranav Loyalka, MD, Kelsey B. Montgomery, BS, Tom C

Sapien XT Transcatheter Mitral Valve Replacement Under Direct Vision in the Setting of Significant Mitral Annular Calcification Takashi Murashita, MD,

Management of High-Risk Patients With Aortic Stenosis and Coronary Artery Disease Daniel Wendt, MD, Philipp Kahlert, MD, Tim Lenze, Markus Neuhäuser,

Transcatheter Aortic Valve Replacement Has Improved Short-Term but Similar Midterm Outcomes in Isolated Aortic Valve Replacement After Prior Coronary.

Brian C. Gulack, MD, Ehsan Benrashid, MD, Robert D. B

Gorav Ailawadi, MD, Damien J. LaPar, MD, MS, Alan M. Speir, MD, Ravi K

Outcomes of Treatment of Nonagenarians With Severe Aortic Stenosis

Laila Hellgren, MD, Elisabeth Ståhle, MD, PhD

Reply The Annals of Thoracic Surgery

Who Do You Say You Are? The Annals of Thoracic Surgery

Valve Thrombosis 7 Months After Transcatheter Aortic Valve Implantation Clarence Pingpoh, MD, Gregor Pache, MD, Diab Nawras, MD, Ludwig Guenkel, MD, Kueri.

Transcatheter Valve-in-Valve Implantation for Deteriorated Aortic Bioprosthesis: Initial Clinical Results and Follow-Up in a Series of High-Risk Patients

The “Double-Valve” Sign in Acute Type A Aortic Dissection

Andreas Zierer, MD, Rochus K. Voeller, MD, Karen E

Use of Amiodarone After Major Lung Resection

Transcatheter Aortic Valve Replacement Outcomes in Nonagenarians Stratified by Transfemoral and Transapical Approach Christian McNeely, MD, Alan Zajarias,

Timothy Lee, BS, Alexander J. C

Prognostic significance of mild aortic regurgitation in predicting mortality after transcatheter aortic valve replacement Brandon M. Jones, MD, E. Murat.

Zain Khalpey, MD, PhD, Wernard Borstlap, Patrick O. Myers, MD, Jan D

Transcatheter aortic valve replacement in intermediate-risk patients

Javier M. Olarte, MD, Fernando D. Lopez, MD, Jose M

Transcatheter Aortic Valve Replacement: How I Teach It

Percutaneous Transcatheter Closure of the Aortic Valve

Embol-X Intraaortic Filter and Transaortic Approach for Improved Cerebral Protection in Transcatheter Aortic Valve Implantation Pierre-Yves Etienne,

Takashi Murashita, MD, Kevin L. Greason, MD, Rakesh M

Redo Aortic Valve Replacement in Children

Heart-Type Fatty Acid Binding Protein and Ischemia-Modified Albumin for Detection of Myocardial Infarction After Coronary Artery Bypass Graft Surgery

Aortic and Mitral Valve Replacement Versus Transcatheter Aortic Valve Replacement in Propensity-Matched Patients Fenton H. McCarthy, MD, Nimesh D. Desai,

Long-Term Survival and Freedom From Reoperation After Placement of a Pulmonary Xenograft Valved Conduit George M. Alfieris, MD, Michael F. Swartz, PhD,

Daniel P. O’Hair, MD, Tanvir K. Bajwa, MD, Jeffrey J

A Change in Perspective: Results for Ischemic Mitral Valve Repair Are Similar to Mitral Valve Repair for Degenerative Disease Leo M. Gazoni, MD, John.

Hybrid Approach for Off-Pump Pulmonary Valve Replacement in Patients With a Dilated Right Ventricular Outflow Tract Diego Porras, MD, Michelle Gurvitz,

Transcatheter Aortic Valve Replacement Versus Aortic Valve Bypass

Acute Esophageal Necrosis: A Case Series and Long-Term Follow-Up

Outcome of Patients With Aortic Stenosis Referred to a Multidisciplinary Meeting for Transcatheter Valve Marjan Jahangiri, FRCS, Jean Claude Laborde,

The Annals of Thoracic Surgery

Invited Commentary The Annals of Thoracic Surgery

Commentary: When a choice is not an echo

Renuka Jain, MD, Mohamed F. Algahim, MD, Tanvir K. Bajwa, MD, Bijoy K

Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H

The Risk and Outcomes of Reoperative Tricuspid Valve Surgery

Ali N. Azadani, PhD, Nicolas Jaussaud, MD, Peter B

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Surgical Management of Supravalvular Aortic Stenosis: Does Brom Three-Patch Technique Provide Superior Results? Olivier Metton, MD, Walid Ben Ali, MD,

Transcatheter Aortic Valve Replacement via Left Anterior Thoracotomy in a Patient With Severe Pectus Excavatum Dan Loberman, MD, Taufiek Konrad Rajab,

Intermediate Follow-Up Results From the Multicenter Engager European Pivotal Trial David Holzhey, MD, PhD, Axel Linke, MD, Hendrik Treede, MD, PhD, Stephan.

Aortic Valve Replacement After Transapical Valve-in-Valve Implantation

Michael O. Kayatta, MD, Bradley G

Successful Transapical Implantation of an Edwards Sapien Valve Within an Insufficient Aortic CoreValve Prosthesis: An Initial Experience Simone Schleger,

Presentation transcript:

Low Incidence of Paravalvular Leakage With the Balloon-Expandable Sapien 3 Transcatheter Heart Valve Daniel Wendt, MD, Fadi Al-Rashid, MD, Philipp Kahlert, MD, Mareike Eißmann, MD, Karim El-Chilali, MD, Rolf Alexander Jánosi, MD, Susanne Pasa, MD, Konstantinos Tsagakis, MD, Oliver Liakopoulos, MD, Raimund Erbel, MD, Heinz Jakob, MD, Matthias Thielmann, MD The Annals of Thoracic Surgery Volume 100, Issue 3, Pages 819-826 (September 2015) DOI: 10.1016/j.athoracsur.2015.03.079 Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Sapien 3 transcatheter heart valve and Certitude delivery system (Edwards Lifesciences, Irvine, CA). The Annals of Thoracic Surgery 2015 100, 819-826DOI: (10.1016/j.athoracsur.2015.03.079) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Changes of mean pressure gradients (MPG, gray line) and aortic valve area (AVA, black line) of patients at risk from baseline to 30 days. The range bars show the standard deviation. The Annals of Thoracic Surgery 2015 100, 819-826DOI: (10.1016/j.athoracsur.2015.03.079) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Moderate (green), mild (red), and none or trace (blue) paravalvular aortic regurgitation (AR) at 30 days. The Annals of Thoracic Surgery 2015 100, 819-826DOI: (10.1016/j.athoracsur.2015.03.079) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Survival after transcatheter aortic valve replacement (TAVR) with the Sapien 3 transcatheter heart valve (Edwards Lifesciences, Irvine, CA) for the total cohort (n = 54). The Annals of Thoracic Surgery 2015 100, 819-826DOI: (10.1016/j.athoracsur.2015.03.079) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions